US Patent 7122552 Inhibitors of JAK and CDK2 protein kinases

Patent 7122552 was granted and assigned to Vertex Pharmaceuticals on October, 2006 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Vertex Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

71225520

Patent Inventor Names

Brian E. Ledford0

Date of Patent

October 17, 2006

Patent Application Number

104497420

Date Filed

May 30, 2003

Patent Citations Received

‌

US Patent 11980633 Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors

‌

US Patent 11667611 Compositions and methods for inhibition of the JAK pathway

Patent Primary Examiner

‌

Deepak Rao

Patent abstract

The present invention provides a compound of formula I:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7122552 Inhibitors of JAK and CDK2 protein kinases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API